Igniting Hope for Tumor Immunotherapy: Promoting the “Hot and Cold” Tumor Transition
The discovery of immune checkpoint inhibitors (ICIs) has ushered a new era for immunotherapy against malignant tumors through the killing effects of cytotoxic T lymphocytes in the tumor microenvironment (TME), resulting in long-lasting tumor suppression and regression. Nevertheless, given that ICIs...
Main Authors: | Chen Wei, Yichao Ma, Fei Wang, Yiqun Liao, Yuji Chen, Bin Zhao, Qi Zhao, Daorong Wang, Dong Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-09-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | https://doi.org/10.1177/11795549221120708 |
Similar Items
-
Dendritic Cell-Based Immunotherapy in Hot and Cold Tumors
by: Byeong Hoon Kang, et al.
Published: (2022-06-01) -
New hope for tumor immunotherapy: the macrophage-related “do not eat me” signaling pathway
by: Han Deng, et al.
Published: (2023-07-01) -
Hot and cold tumors: Immunological features and the therapeutic strategies
by: Lianjie Wang, et al.
Published: (2023-10-01) -
Potential Ability of Probiotics in the Prevention and Treatment of Colorectal Cancer
by: Jiahao Zhao, et al.
Published: (2023-08-01) -
Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?
by: Nathan Karin
Published: (2021-12-01)